System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Imam Waked, MD, FRCP is an expert in Hepatology at Menoufia University (Egypt). As of June 2026, ScienceLeadR ranks Imam Waked in the top 1% of experts worldwide for Hepatitis, and in the top 1% of experts in Egypt for Liver Neoplasms and Carcinoma. Imam Waked has authored 203 publications, the most recent in 2026, and is an investigator in 7 clinical trials, 1 of them ongoing. SLR score: 721 (community average: 125). How the SLR is computed.

LeadR Profile

Imam Waked, MD, FRCP Menoufia University Egypt
721 ScienceLeadR Reputation 721

Unlock

Register Login
Network Map

Hepatology

Subspecialties: Gastroenterology - Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1995 - 2026
Source: PubMed

Menoufia University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 203

Citations

Citations: 11 334 1st author: 13 Last author: 83 Unique author: 3

Main journals

J Hepatol 32
Lancet Gastroenterol Hepatol 14
Arab J Gastroenterol 10
Liver Int 9
J Viral Hepat 8

Best Journals

Lancet Gastroenterol Hepatol 7
J Hepatol 3
J Clin Oncol 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Alcohol-associated Liver Disease in the MENA Region: A 16-Country Survey of Healthcare Provider Perspectives.
PMID 42303045 — liver diseases, liver, prevalence, health personnel		Ann Hepatol20260
Denominator bias in MENA MASLD epidemiology: A call for decision-grade surveillance.
PMID 42262771 — bias, epidemiology, prevalence, gastrointestinal diseases		Saudi J Gastroenterol20260
Double-barreled drug-induced liver injury and the unmasking of latent primary biliary cholangitis: A case of amoxicillin-clavulanate and warfarin interaction.
PMID 42031612 — polypharmacy, cholangitis, pharmaceutical preparations, amoxicillin, liver, warfarin, hepatitis		Arab J Gastroenterol20260
Risk Stratification and Validation of ICU Scores in Prediction of Post-ERCP Mortality for Critically Ill Patients With Severe Acute Cholangitis Based on Tokyo Guidelines 2018.
PMID 41661171 — cholangiopancreatography, endoscopic retrograde, mortality, cholangitis, gastroenterology, critical illness, intensive care units		J Clin Gastroenterol20260
HCC risk stratification scores: insights from large multi-center national cohort study.
PMID 41634060 — multiple chronic conditions, cohort studies, natural science disciplines		Sci Rep20260

Clinical Studies 7

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 3
Phase 2 2
Phase 1/Phase 2 1
Phase 2/Phase 3 1

By status:

Completed 5
Recruiting 1
Unknown 1

By type:

Interventional 7

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 3
multicentric5to9 0
multicentricup10 2

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Clinical Pharmacogenetic Study of Sorafenib in Egyptian Patients With Hepatocellular Carcinoma
NCT06527495 — carcinoma, hepatocellular, safety, sorafenib, tablets, carcinoma		Phase 1/Phase 2Recruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS